Medical Devices & Supplies · Medical Distributors · NSE: AAKAAR · data 2026-10-30

Aakaar Medical Technologies Limited

₹71+1.50% on 29 OctHealth: Strong 7.9/10

Dec 2025Low ₹48 · High ₹81.95+0.6%

In plain words

Price: 21.1% below its 52-week high of ₹89.95.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹71

Market cap

₹101 cr

P/E

15.2

P/B

1.8

ROE

17.1%

ROCE

25.8%

Debt / equity

0.34

Dividend yield

0.00%

1-year return

-15.5%

52-week high

₹89.95

52-week low

₹46

Operating margin

15.0%

Growth

Revenue (last 12 months)	₹67 cr
Net profit (last 12 months)	₹7 cr
Sales growth, 3 years (yearly)	27.1%
Profit growth, 3 years (yearly)	45.5%

Smart-money activity

5/100 · Weak over the last ~60 sessions

Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Aakaar Medical Technologies Limited debt-free?

Its latest reported debt-to-equity ratio is 0.34.

What is Aakaar Medical Technologies Limited's P/E ratio?

About 15.2, based on the last 12 months' earnings and a price of ₹71 (data 2026-10-30).

What is the 52-week high and low of Aakaar Medical Technologies Limited?

The 52-week high is ₹89.95 and the 52-week low is ₹46.

Similar companies

QMS Medical Allied Services Limited (QMSMEDI) · Vijaypd Ceutical Limited (VIJAYPD) · Balaxi Pharmaceuticals Limited (BALAXI) · Vivo Bio Tech Ltd. (VIVOBIOT) · Mono Pharmacare Limited (MONOPHARMA)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open AAKAAR in NSE Scanner →